Evommune, Inc. Common Stock (EVMN)

Cash & Short-Term Investments

$200.79M

Quarterly · Period ending: · USD

EVMN logo

EVMN Cash & Short-Term Investments

Latest reported$200.79M
EVMN Quarterly Cash & Short-Term Investments ($72.04M → $200.79M)
High-resolution chart · PNG

EVMN cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
200,793,000
211,464,000
149,200,000
76,062,000
86,795,000
48,414,000
72,040,000
72,040,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.